All contributors
Onconephrology contributor
Terpos, Evangelos
Primarily Myeloma cast nephropathy#8 of 46 recognizedHonor roll
- #4 in Myeloma cast nephropathy
67
Clinical papers
8,111
Citations (iCite)
13 / 8
First / senior author
2006–2026
Active years
Output over time
Clinical corpus papers per year — peak 6 in 2016, 2021, 2025.
- 2006: 1 paper
- 2007: 1 paper
- 2008: 2 papers
- 2009: 3 papers
- 2010: 5 papers
- 2011: 3 papers
- 2012: 4 papers
- 2013: 3 papers
- 2014: 4 papers
- 2015: 2 papers
- 2016: 6 papers
- 2017: 1 paper
- 2018: 5 papers
- 2019: 2 papers
- 2020: 4 papers
- 2021: 6 papers
- 2022: 1 paper
- 2023: 3 papers
- 2024: 2 papers
- 2025: 6 papers
- 2026: 3 papers
20062026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Myeloma cast nephropathy60
MGRS & paraprotein kidney disease22
Cellular therapy renal effects3
Anticancer drug nephrotoxicity1
Frequent co-authors
Other recognized contributors who most often share corpus papers with Terpos (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists Terpos among the leading contributors (clinical-paper count on that agent).
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,541-article corpus (regenerated 2026-10-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.